Receiving a deficiency letter from Nasdaq is a significant negative regulatory event that indicates the company's stock is not meeting the minimum bid price requirement. This could lead to delisting if not addressed, which typically has a negative impact on the stock price in the short term due to investor concerns about the company's ability to maintain its listing and the potential decrease in liquidity and investor interest.